MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-18-2026
Alcon Cash and Cash Equivalents 2011-2026 | ALC
Annual Cash and Cash Equivalents Alcon
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.53 B | 1.68 B | 1.09 B | 980 M | 1.58 B | 1.56 B | 822 M | 227 M | 172 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.68 B | 172 M | 1.07 B |
Quarterly Cash and Cash Equivalents Alcon
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 1.58 B | - | 1.37 B | - | 1.56 B | - | 1.32 B | - | 822 M | - | 721 M | - | 227 M | - | 151 M | - | 172 M | - | - | - | 162 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.58 B | 151 M | 808 M |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
111 M | $ 60.58 | 0.33 % | $ 12.1 B |  USA |
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M | USA |
 |
iRhythm Technologies
IRTC
|
236 M | $ 115.46 | 1.14 % | $ 3.7 B | USA |
 |
ICU Medical
ICUI
|
308 M | $ 120.37 | -2.13 % | $ 2.97 B | USA |
 |
Repro Med Systems
KRMD
|
8.87 M | $ 3.87 | -2.76 % | $ 179 M | USA |
 |
Intuitive Surgical
ISRG
|
3.37 B | $ 421.73 | -1.48 % | $ 151 B | USA |
 |
LeMaitre Vascular
LMAT
|
28.2 M | $ 97.52 | -1.99 % | $ 2.21 B | USA |
 |
Masimo Corporation
MASI
|
178 M | $ 178.4 | 0.03 % | $ 9.51 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
1.17 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.21 B | $ 23.69 | -0.67 % | $ 3.98 B | USA |
 |
electroCore
ECOR
|
7.04 M | $ 6.29 | -2.18 % | $ 53.4 K | USA |
 |
Haemonetics Corporation
HAE
|
307 M | $ 56.6 | -0.86 % | $ 2.85 B | USA |
 |
STAAR Surgical Company
STAA
|
153 M | $ 32.27 | 0.81 % | $ 1.6 B | USA |
 |
STERIS plc
STE
|
172 M | $ 214.08 | -0.88 % | $ 21.1 B | USA |
 |
Teleflex Incorporated
TFX
|
379 M | $ 128.92 | -1.04 % | $ 5.75 B | USA |
 |
Isoray
ISR
|
30.6 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
93.5 M | $ 141.43 | -0.52 % | $ 6.85 B | USA |
 |
InfuSystem Holdings
INFU
|
3.19 M | $ 8.57 | -0.46 % | $ 177 M | USA |
 |
Microbot Medical
MBOT
|
3.91 M | $ 1.93 | 4.32 % | $ 88.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
1.11 M | $ 0.33 | -1.64 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
446 M | $ 62.4 | -0.26 % | $ 3.69 B | USA |
 |
Utah Medical Products
UTMD
|
85.8 M | $ 63.24 | -0.72 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
791 M | $ 301.39 | 0.4 % | $ 21.8 B | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 24.12 | -11.01 % | $ 1.63 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
326 M | $ 10.04 | -3.6 % | $ 2 B | USA |
 |
Retractable Technologies
RVP
|
2.59 M | $ 0.69 | - | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 59.95 | 2.22 % | $ 197 M | USA |
 |
Predictive Oncology
POAI
|
10.8 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
33 M | $ 20.55 | -2.42 % | $ 981 M | USA |
 |
Stereotaxis
STXS
|
13.4 M | $ 1.87 | -3.86 % | $ 170 M | USA |
 |
Baxter International
BAX
|
1.97 B | $ 17.32 | -2.64 % | $ 8.89 B | USA |
 |
ResMed
RMD
|
274 M | $ 202.53 | -0.01 % | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
167 M | $ 28.37 | 0.79 % | $ 1.35 B | USA |
 |
Harvard Bioscience
HBIO
|
8.61 M | $ 5.36 | -2.9 % | $ 238 M | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 10.88 | -1.36 % | $ 444 M | USA |
 |
Becton, Dickinson and Company
BDX
|
641 M | $ 142.79 | -1.2 % | $ 41.1 B | USA |
 |
Nephros
NEPH
|
5.4 M | $ 3.16 | -5.39 % | $ 33.5 M | USA |
 |
OraSure Technologies
OSUR
|
199 M | $ 3.08 | 4.24 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
566 M | $ 105.36 | 1.91 % | $ 5.92 M | USA |